Literature DB >> 6134148

Human parvovirus, the cause of erythema infectiosum (fifth disease)?

M J Anderson, S E Jones, S P Fisher-Hoch, E Lewis, S M Hall, C L Bartlett, B J Cohen, P P Mortimer, M S Pereira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6134148     DOI： 10.1016/s0140-6736(83)92152-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  90 in total

1.  Genetic diversity within human erythroviruses: identification of three genotypes.

Authors:  Annabelle Servant; Syria Laperche; Francis Lallemand; Valérie Marinho; Guillemette De Saint Maur; Jean François Meritet; Antoine Garbarg-Chenon
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 2.  Molecular techniques in the diagnosis of human infectious diseases.

Authors:  U Desselberger; K Collingham
Journal:  Genitourin Med       Date:  1990-10

Review 3.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

4.  Two anti-parvovirus B 19 IgM capture assays incorporating a mouse monoclonal antibody specific for B 19 viral capsid proteins VP 1 and VP 2.

Authors:  H J O'Neill; P V Coyle
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

5.  Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity.

Authors:  Ning Zhi; Ian P Mills; Jun Lu; Susan Wong; Claudia Filippone; Kevin E Brown
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Identification and mapping of neutralizing epitopes of human parvovirus B19 by using human antibodies.

Authors:  H Sato; J Hirata; N Kuroda; H Shiraki; Y Maeda; K Okochi
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

7.  Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens.

Authors:  J P Clewley
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

8.  Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus.

Authors:  C H Srivastava; R J Samulski; L Lu; S H Larsen; A Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  Down-regulation of inwardly rectifying Kir2.1 K+ channels by human parvovirus B19 capsid protein VP1.

Authors:  Musaab Ahmed; Bernat Elvira; Ahmad Almilaji; C-Thomas Bock; Reinhard Kandolf; Florian Lang
Journal:  J Membr Biol       Date:  2014-12-09       Impact factor: 1.843

10.  Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity.

Authors:  Claudia Bönsch; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.